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Summary To assess the weaning outcome of lung cancer patients with acute
respiratory failure (ARF) requiring mechanical ventilation, we retrospectively
analyzed the database of the respiratory intensive care unit at a university-affiliated
tertiary care hospital.
Charts were reviewed for cancer status, biochemistries before respiratory failure,
causes of respiratory failure, acute physiology and chronic health evaluation
(APACHE) III score, ventilatory settings, data recorded during spontaneous breathing,
duration of ventilator days, and weaning outcome. Ninety-five consecutive
respiratory failure events in 81 patients were recorded from January 1, 1995 through
June 30, 1999.
Twenty-six episodes ended with successful weaning (27.4%). Age, gender, and
cancer status did not affect the weaning outcome. Serum albumin level, APACHE III
score, highest fractional inspired O2 (FiO2) and highest positive end-expiratory
pressure, organ failure, ability to shift to partial ventilatory support, and duration of
mechanical ventilation could significantly influence the weaning outcome statisti-
cally. The overall hospital mortality rate was 85.2%.
Our results suggested that lung cancer patients with ARF will have a better chance
to wean if the initial APACHE III score was less than 70, use of FiO2 never exceeded
0.6, or less than 2 additional organ systems failed during the treatment course.
& 2003 Elsevier Ltd. All rights reserved.
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Introduction
Acute respiratory failure (ARF) is a common
complication in patients with lung cancer and
implies a poor prognosis. Mechanical ventilation in
these patients presents dilemmas in medical
management, philosophy, and ethics. It can be
lifesaving on the one hand or be the beginning of a
long and painful death on the other. Despite the
progress in treating lung cancer and managing
respiratory failure, a definite strategy for lung
cancer patients with respiratory failure is still not
established. To identify those who would have
benefits from the ventilatory support is therefore
crucial. Reviewing the literature reveals only one
article concerning the outcome of lung cancer
patients with ARF.1
Respiratory failure in critically ill cancer patients
indicate poor prognosis.2–8 Mortality in the inten-
sive care unit (ICU) ranged from 54.5% to 91.1%1,4
and hospital mortality varied from 63.2% to
95.6%.2,9–13 The mortality rate in lung cancer
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patients associated with ARF is much higher as
compared with those induced by other diseases,
such as pneumonia, chronic obstructive pulmonary
disease (COPD), and septic shock.14–17 Pertinent
literatures suggested thoroughly considering initia-
tion or withholding and withdrawing the life
support because of the high mortality rate and
the expense of intensive care in critical cancer
patients.6,14 However, there are no acceptable
guidelines to help managing critically ill lung
cancer patients with ARF.
A variety of factors may cause respiratory failure
among lung cancer patients. COPD is a common
concomitant disease,18–20 since most of the pa-
tients with lung cancer have been heavy smokers.
The rate of lung cancer patients with COPD
reported in previous studies ranged from 22.0% to
64.6%.19–20 Therefore, either lung cancer itself or
other reversible conditions such as infections and
bronchospasm may contribute to ARF. To separate
the degree of functional impairment attributable
to reversible etiologies from that caused by
irreversible factors is extremely difficult.1
Many factors affecting the outcome in different
cancer patients had been proposed. These factors,
which attracted some controversy, included acute
physiology and chronic health evaluation (APACHE)
II3,6,9,11,16 and III8,12 scores, simplified acute
physiological score,22 cancer type,10 hepatic,7,23
cardiovascular,7,13 renal,23 and neurological fail-
ures,8,23 persisted leucopenia,9,23 thrombocytope-
nia,23 disseminated intravascular coagulation
(DIC),13 an increasing number of organ system
dysfunctions,2,6,9,11,13,14,21,23 septic shock,8,11,22
pulmonary infiltrates on chest radiograph,3,17 re-
quirement of a high fractional inspired O2 (FiO2),
16
duration of mechanical ventilation,1,5 length of ICU
stay,6,22 and low serum albumin.16,17
Most of the authors had focused on the outcome
of mortality. However, to use mechanical ventila-
tion does not imply terminal illness. Clinical
experience reveals that some patients may be
weaned from a mechanical ventilator even in an
advanced cancer stage. Identifying the predictors
of the ability to liberate from mechanical ventila-
tion will be very helpful for clinicians. This study
aimed to disclose clinical variables associated with
successful weaning from mechanical ventilation
among lung cancer patients with ARF.
Materials and methods
Data were retrospectively collected in a university-
affiliated tertiary care hospital from January 1,
1995 to June 30, 1999. The investigation included
all patients with lung cancer requiring mechanical
ventilation for more than 24 h. Ninety-five episodes
in 81 patients were eligible for data analysis from a
total of 1497 ICU admissions. Factors recorded
included: (1) demographic data; (2) cancer status;
(3) relevant laboratory values and clinical condi-
tions before respiratory failure; (4) causes of
respiratory failure; (5) conditions during mechan-
ical ventilation, including APACHE III score, tidal
volume (VT), maximal inspiratory pressure (Pimax),
highest FiO2, highest positive end-expiratory pres-
sure (PEEP), ability to shift from full mechanical
ventilatory support to partial support mode within
48 h, and duration of mechanical ventilation; organ
system(s) dysfunction, in addition to the respira-
tory system, during mechanical ventilation; and6
weaning outcome and mortality.
Pathology or cytology determined the cell type of
tumors and the cells were classified as small cell or
non-small cell types. The cancer stage was re-
corded by the TNM (T: primary tumor, N: regional
lymph nodes, M: distant metastasis) system24 based
on the status before respiratory failure. The
location of tumors was defined as central, for
tumors located up to the segmental orifice, or
peripheral, for all other locations. Airway obstruc-
tion was defined as occlusion of airway by tumors
documented during bronchoscopic examination, or
the appearance of obstructive pneumonitis on
chest radiograph.
The arterial blood gas and blood chemistry values
were those obtained in the last evaluation before
ARF. Documented diseases such as COPD were
retrieved from the medical records as associated
diseases.
The cause of respiratory failure was also re-
corded. Disease progression was defined as respira-
tory failure caused by airway obstruction due to
tumor mass or diffuse tumor invasion of the lungs.
Systolic blood pressure lower than 90mmHg and not
of cardiac origin or sepsis was categorized as shock
group. Respiratory failure caused by congestive
heart failure or cardiac dysarrhythmia was defined
as cardiac origin.
Data from the first profile taken during mechan-
ical ventilation determined the ‘after respiratory
failure’ evaluations. The APACHE III score calcu-
lated according to the system of Knaus et al.25 was
obtained within 24 h after mechanical ventilation
was initiated.
The criteria for organ failure were modified from
previous investigations,6,14 and were evaluated at
least 48 h before death. Cardiovascular failure
implied life-threatening cardiac dysarrhythmia, or
congestive heart failure. Diagnosing renal failure
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required a serum creatinine above 2mg/dl or a
24-h urine output of less than 600ml. Gastrointest-
inal failure was defined as upper gastrointestinal
bleeding requiring transfusion of more than two
units of blood and prolonged ileus (45 days). A
Glasgow coma scale score26 of less than 6 without
sedation was taken to indicate neurological failure.
Hematological failure required a platelet count
below 50,000mm3, a WBC count below 1000mm3,
the presence of DIC, and a hematocrit below 20%.
All patients in our ICU were screened routinely
each morning between 9:00 and 9:30 by the
respiratory therapists. The Pimax and was measured
by a haloscale during a 30-s spontaneous breathing
test and VT was obtained by dividing the minute
ventilation by the respiratory frequency. The
weaning protocol was the same for all patients in
our ICU. The decision of shifting ventilatory setting
to partial support mode was judged by in-charge
attending physician. When a low-level pressure
support ventilation (6–8 cm H2O) was successful, a
2-h T-piece trial was arranged accordingly. The
patient was liberated from ventilator if he or she
could tolerate the spontaneous breathing test. If
the patient could not tolerate the low-level
pressure support mode, the T-piece trial would be
used for weaning, in which the length of T-piece
trial was increased, with alternating periods of
ventilatory support and the T-piece trial. The
decision to perform extubation was made by the
patient’s attending physician. If the respiratory
distress developed, such as diaphoresis, conscious
disturbance, agitation, and increased partial pres-
sure of arterial carbon dioxide accompanied by a
pH of 7.30 or less, the patients would be
reintubated.
The outcome was subclassified into weaned,
defined as survival for more than 72h after liberating
from mechanical ventilation, and unweaned groups.
The correlation of the variables with the weaning
outcome was analyzed statistically.
Statistics
Data are presented as mean7standard deviation
(SD). Two-tailed Student’s t test was employed for
comparisons between groups for continuous vari-
ables. Discrete variables were examined by the chi-
square test first. If 25% of the cells had expected
counts of less than 5, they were re-examined with
Fisher’s exact test. Po0:05 was considered statis-
tically significant. Statistically significant variables
in univariate analysis, patient age, and gender
were then examined by logistic regression analysis.
The grouping cut-off levels were adjusted accord-
ing to the mean levels of the weaned and unweaned
groups. All statistical computations were per-
formed by SAS software (SAS Institute Inc, Cary,
NC).
Results
Ninety-five respiratory episodes in 81 patients with
lung cancer complicated by respiratory failure were
treated with mechanical ventilation during the
study period (Table 1). Twelve patients had two
respiratory failure episodes and one had three
episodes. The interval between respiratory epi-
sodes ranged from 15 to 74 days (mean 49.55 days).
Males predominated. All 22 small cell lung cancers
were in extensive stage disease and were categor-
ized as stage IV disease. The weaning rate was
27.4%. Among the 12 patients who could be
discharged from our hospital, two patients were
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Table 1 Demographic data.
No. of patients 81
Age (years)
Mean 67.46710.01
Range 31–88
Sex
Male 81 (85.3%)
Female 14 (14.7%)
Cell type
Small cell 22 (23.2%)
Non-small cell 73 (76.8%)
Squamous cell 29 (30.5%)
Adenocarcinoma 32 (33.7%)
Large cell 1 (1.1%)
Non-Small cell 11 (11.6%)
Stage
Stage I 1 (1.1%)
Stage II 3 (3.2%)
Stage III 35 (36.8%)
Stage IV 56 (58.9%)
Weaned
Yes 26 (27.4%)
No 69 (72.6%)
Outcome
ICU mortality 59 (72.8%)
Hospital mortality 69 (85.2%)
Survivor 12 (14.8%)
Data were expressed as mean7SD.
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still alive at the time of data collection. The
survival time of the other 10 patients ranged from 6
to 302 days (mean 61.53 days).
Because the number was too small (1 stage II and
3 stage II), cancer stage I–III disease were included
in stage I–III group. Table 2 summarizes the cancer
status of the patients before respiratory failure. All
factors had no influence on the probability of
weaning. 12 lung cancer patients were diagnosed
after respiratory failure. Half of our patients did
not receive chemotherapy or radiotherapy. In
addition, no chemotherapy or endobronchial treat-
ment was done in our patients when the ARF was
related to progression of the cancer.
Table 3 lists the blood chemistry and gas values
before respiratory failure in the two groups. Only
the serum albumin level differed significantly in
these two groups of patients. The mean age and
gender did not vary between the weaned and the
unweaned groups. The presence of COPD or
diabetes mellitus did not affect the probability of
successful weaning.
Table 4 summarizes the causes of respiratory
failure. The various causes revealed no significant
differences.
The mean APACHE III score was significantly lower
in the weaned group than in the unweaned group
(Table 5). The unweaned group exhibited higher
mean VT and lower Pimax than the weaned group
but the difference was insignificant. The highest
FiO2 and PEEP required during mechanical ventila-
tion were significantly higher in those who were not
successfully weaned. The duration of mechanical
ventilation was found to be significantly longer in
the unweaned group. Patients whose mechanical
ventilator mode could be switched to partial
support within 48 h displayed a better prognosis.
Cardiovascular failure, gastrointestinal failure
and neurological failure were all associated with
poor weaning outcome. Moreover, the mean num-
ber of failed organ systems was higher in the
unweaned group (data not shown).
Table 6 lists the result of logistic regression. The
APACHE III score, shifting to partial support mode
with 48 h after respiratory failure, high FiO2,
duration of mechanical ventilation, and number
of organs failed were positive predictors.
We also analyzed factors affecting hospital
mortality (data not shown). Prognostic factors are
those which reflect underlying chronic condition
ARTICLE IN PRESS
Table 2 Cancer status before respiratory failure.
Weaned (26) Unweaned (69) P value
Cell type
Non-small cell 19 (26.0%) 54 (74.%) 0.59
Small cell 7 (31.8%) 15 (68.2%)
Stage
Stage I–III 10 (25.6%) 29 (74.4%) 0.75
Stage IV 16 (28.6%) 40 (71.4%)
Location (two missing data)
Central 12 (30.0%) 28 (70.0%) 0.56
Peripheral 13 (24.5%) 40 (75.5%)
Obstruction (two missing data)
Yes 12 (24.5%) 37 (75.5%) 0.58
No 13 (29.6%) 31 (70.4%)
Time between lung cancer diagnosis and respiratory failure (days)
106.317215.25 156.047263.53 0.35
Previous treatment
None 15 (31.3%) 33 (68.7%) 0.27
C/Tn alone 2 (10.5%) 17 (89.5%)
R/Tw alone 6 (37.5%) 10 (62.5%)
C/TþR/T 3 (25.0%) 9 (75.0%)
Values expressed as mean7SD unless otherwise indicated. Data were not available for all patients.
nChemotherapy.
wRadiotherapy.
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such as the ability to wean, serum albumin level,
duration of mechanical ventilation and ICU stay,
and the occurrence of cardiovascular failure. But
factors reflecting acute status such as the APACHE
III score during mechanical ventilation were not
correlated well with the prognosis.
Discussion
This study, like Ewer’s work,1 aimed at the weaning
outcome but not the mortality per se, which was a
different approach from the previous studies. In the
long run, we considered that the weaning outcome
could be treated as a form of immediate outcome
and the mortality as a final outcome. The immedi-
ate outcome for such patients who had an
untreatable disease was of more concern than the
final outcome to the intensive care physicians, the
families, and even the patients themselves.
Despite aggressive intensive care, the weaning
and survival rates of our patients were low, which
confirmed the report by Snow.23 Even when lung
cancer patients can be weaned, their long-term
survival remains poor. The result also demonstrated
that the mortality rate of cancer patients with ARF
remains high despite significant advances in sup-
portive management in ICU and ventilatory strate-
gies in recent years.27
In our study, the serum albumin level, highest
FiO2, PEEP required during mechanical ventilation,
the presence of cardiovascular, gastrointestinal
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Table 3 Conditions before respiratory failure.
Weaned Unweaned P value
Age 68.8578.10 66.94710.65 0.35
Gender
Male 22 (27.2%) 59 (72.8%) 0.91
Female 4 (28.6%) 10 (71.4%)
Associated diseases
COPD
Yes 12 (35.3%) 22 (64.7%) 0.20
No 14 (23.0%) 47 (77.0%)
DM
Yes 3 (33.3%) 6 (66.7%) 0.67
No 23 (26.7%) 63 (73.3%)
Biochemical profile
Sodium (meq/dl) 136.9678.40 134.1377.20 0.14
Potassium (meq/dl) 3.6571.00 4.0771.04 0.08
Calcium (meq/dl) 8.3271.04 8.4771.38 0.57
Albumin (g/dl) 3.0670.43 2.5770.51 o0.001
Arterial blood gas
pH 7.3870.13 7.3470.13 0.27
PaO2 (mmHg) 77.23738.03 68.32725.74 0.28
PaCO2 (mmHg) 49.82722.11 52.30722.40 0.63
HCO3 (meq/l) 28.2378.90 27.9078.27 0.87
Values expressed as mean7SD unless otherwise indicated. Data were not available for all patients. COPD denotes chronic
obstructive pulmonary disease, DM diabetes mellitus, PaO2 the partial pressure of arterial oxygen, PaCO2 the partial pressure of
arterial carbon dioxide, and HCO3 the concentration of arterial bicarbonate.
Table 4 Causes of respiratory failure.
Etiology Weaning outcome P value
Weaned Unweaned
Cancer progression 4 13 0.87
Chemotherapy 2 4
Shock 0 3
Sepsis 5 14
PPUn 0 1
Pneumonia 11 24
COPDw 3 7
Cardiac origin 1 3
Subtotal 26 69
nPerforated peptic ulcer.
wChronic obstructive pulmonary disease.
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failure, neurological failures, the sum of organ
failures, duration of mechanical ventilation, and
APACHE III score influenced the weaning outcome.
Patient’s age, as in Ewer’s1 report, and gender did
not influence the weaning outcome. Most authors
agreed that age1,5,8,10,16,22,23,28 and gender5,6 are
not significant predictors of mortality. In one study,
age did affect the mortality.12 Different disease
categories, disease severity, different institutions,
and, possibly, different analytic methods may have
caused the different results. Another, more reason-
able explanation suggests that age does not
contribute significantly to patient outcome inde-
pendently from organ system dysfunction.6
The cancer status, including the cell type, stage,
and previous treatments, did not influence the
result. According to Ewer et al.,1 the tumor cell
type does not correlate to successful weaning. This
may be because respiratory failure itself in lung
cancer patients indicates just as ominous an out-
come as in other cancer patients.2,3,6–8
Among other parameters documented before
respiratory failure, only serum albumin level
carries prognostic significance. The weaned group
exhibited higher albumin level. Albumin is fre-
quently utilized to estimate the nutritional status
of patients and hypoalbuminemia represents, to
some degree, the status of malnutrition. Malnutri-
tion influences respiratory function in a number of
adverse ways. Studies have demonstrated that
malnutrition decreases the ventilatory response to
hypoxia,29 diminishes muscle mass and thickness,
and reduces respiratory muscle strength and
endurance.30,31 Malnutrition also alters host de-
fenses and predisposes the patient to nosocomial
pneumonia, which places an additional load on the
respiratory system.29 Studies have demonstrated
that low serum albumin levels were associated with
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Table 5 Parameters after respiratory failure.
Weaned Unweaned P value
APACHE III scoren 52.23721.05 72.65723.08 o0.001
Weaning profile
Tidal volume (ml) 221.827116.24 216.607103.07 0.86
Pimax (cm H2O) 30.32711.50 33.02711.40 0.36
Highest FiO2 0.5470.20 0.7870.23 o0.001
Highest PEEP (cm H2O) 5.6273.03 8.1273.73 0.002
Duration of ventilator (days) 7.3576.94 18.33723.55 o0.001
Partial support modew
Yes 18 (50.0%) 18 (50.0%) 0.01
No 8 (13.6%) 51 (86.4%)
Values expressed as mean7SD unless otherwise indicated. Data were not available for all patients. FiO2 denotes the partial
pressure of arterial oxygen, and PEEP the positive end-expiratory pressure.
nScores on the acute physiological and chronic health evaluation (APACHE) III can range from 0 to 299. Higher scores indicate a
worse outcome.
wShift to partial support mode within 48 h after initiation of mechanical ventilation.
Table 6 Result of logistic regression.
Variable Standardized estimate Odd ratio P value
Gender 0.026 0.87 0.93
Age 0.29 1.05 0.40
APACHE III score 0.90 0.93 0.03
Albumin 0.57 6.71 0.06
Partial supportn 0.57 8.20 0.046
Highest FiO2 0.95 0.001 0.008
Total organ failure 1.26 0.135 0.02
MV duration 1.47 0.88 0.03
APACHE III denotes acute physiological and chronic health evaluation III, FiO2 the partial pressure of arterial oxygen, MV the
mechanical ventilation.
nShift to partial support mode within 48 h after initiation of mechanical ventilation.
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poor prognosis in different disease states.16,17
Albumin may be administered to patients with
hypoalbuminemia for various reasons. A recently
published meta-analysis32 indicates that adminis-
tering albumin does not influence mortality. How-
ever, it has not been determined whether
correcting the albumin level will improve weaning
outcome in critically ill lung cancer patient.
The analysis of the causes of ARF did not allow us
to identify the subgroups bearing a better prog-
nosis. Those patients whose ARF was caused by
cancer exhibited a higher mortality rate.14 How-
ever, we could not prove the prognostic difference
between the groups. The result is comparable to a
previous study.1 The fact that the respiratory
failure itself indicated poor outcome in cancer
patients may explain it.2–8
The number of dysfunctional organ systems has
been identified as an important indicator of
prognosis in critically ill patients.2,6,9,11,13,14,22,23
The unweaned group in this study also displayed a
higher mean number of dysfunctional organ sys-
tems. The study of Dees and colleagues11 indicated
that patients with three failed organ systems had
mortality rates as high as 84%. In our study, no
patient with three or more failed organ systems in
addition to the respiratory system survived. On the
other hand, the absence of organ failure does not
guarantee successful weaning. Among the organ
systems, cardiovascular, gastrointestinal, and neu-
rological failures were associated with less favor-
able outcome in this study.
The highest FiO2 and PEEP needed, and the
ability to shift to partial ventilatory support but not
the VT or Pimax were prognostic predictors. These
factors reflected the severity of the patients’
respiratory insufficiency. A previous article16 re-
vealed that the non-survivals in general medical
ICU needed higher FiO2. However, no previous
record, at least in cancer patients, mentioned the
ability to shift to partial ventilatory mode as a
predictor of weaning outcome. The duration of
mechanical ventilation was shorter in our weaning
group. However, whether the duration of mechan-
ical ventilation can predict mortality in cancer
patients is a controversial issue.1,5,10,12 The dura-
tion of mechanical ventilation is closely related to
the general condition of the individual patient. The
major determinant of the duration of ventilatory
days should be severity, reversibility, and the time
needed to recover from the acute problems causing
respiratory failure. It should not simply be an issue
of shorter or longer duration of mechanical
ventilation. Other possible explanation for the
controversy is the lack of a suitable weaning
protocol in some studies.
Increased APACHE III or modified APACHE III score
reflected positive predictors, as mentioned above.
The unweaned group had higher score, just as other
studies reported upon mortality.8,12 Similar findings
were noted with APACHE II.3,9 In Staudinger’s
group, all patients with APACHE III scores above
80 died at ICU.8 In our group, by contrast, two were
weaned among those whose scores exceeded 80 (2/
24). A single variable, even the APACHE III score, is
insufficient to predict the outcome for an individual
patient.
Although the lung cancer treatment plans have
made progress and many new ventilator strategies
have also been developed in recent years, the
prognosis for patients with lung cancer complicated
by respiratory failure remains unfavorable. Since
no single factor including the APACHE III score
should determine decisions about therapy prolon-
gation,8 we analyzed the weaning outcome based
on the combination of APACHE III score, highest
FiO2, and total number of organ systems failed. In
this model, no one (0/10) could be weaned from
ventilator if APACHE III score exceeded 70, highest
FiO2 were greater than 0.6, and more than two
additional organs failed. Since those who could not
be weaned from ventilator eventually died, this
model also predicted the mortality.
Avoiding intubation should be an important issue
in patients bearing this untreatable disease. Non-
invasive ventilation may avert intubation and
serious complication caused by intubation in
selected immunocompromised patients.33 It may
also be a palliative support in end-stage cancer
patients. But how to select patients who would
most benefit from this approach remains unclear.
On the basis of our data, only serum albumin level
recorded before respiratory failure was a signifi-
cant predictor of weaning outcome.
This analysis has some drawbacks. First, these
subjects were lung cancer patients treated in a
tertiary academic medical center and the severity
of their illness may be differed from those in other
hospitals. Indications for initiating mechanical
ventilation may also differ between institutions,
and the outcome may be favorable in other settings
because the patients suffer less severe illnesses.
Moreover, the 95 respiratory events were derived
from 81 patients. The influence on the data of the
individuals having more than one episode of
respiratory failure would be greater than that of
the other patients. But if only the first or last
respiratory episode were recorded, the sampling
bias will occur. We therefore treated respiratory
failures in the same patients as different events.
Actually, we also analyzed the data excluding those
who experienced more than one respiratory failure
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event, and this change produced a similar result
(data not shown).
In addition, this analysis was directed at the
weaning outcome but not the mortality. As men-
tioned above, published data were limited. We
therefore compared our results with those regard-
ing mortality. Moreover, our results are limited by
the retrospective design and the small sample size.
Nevertheless, our results provide scientific guides
for physicians who take care of critically ill cancer
patients for prognosis explanation and decision
making. This will, of course, need further large-
scale prospective randomized studies to verify. At
last, although our model may predict outcome in
groups of critically ill lung cancer patients, the
decision to each patient should be made indepen-
dently in each case.
Conclusions
Even with the disappointed result, 27.4% of ARF
episodes could be weaned. The weaned group had
higher albumin level, less ventilatory support,
lower APACHE III score, and less failed organs.
In this study, lung cancer patients with respira-
tory failure who have less than two organs failure
during the course, use FiO2 in mechanical ventila-
tion less than 0.6, and have initial APACHE III score
less than 70 will have a better chance to be weaned
from mechanical ventilation. We believe this retro-
spective study provides a scientific data and a
different viewpoint for managing lung cancer
patients with ARF.
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